ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY

Aim. To study antihypertensive efficacy and safety of valsartan (Diovan, Novartis Pharma) as well as patient’s compliance to the mono- or combined valsartan based therapy in smoking vs non-smoking hypertensive patients.Material and methods. It was a prospective multicenter observation study. 114 doc...

Full description

Bibliographic Details

Published in:	Рациональная фармакотерапия в кардиологии
Main Authors:	V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Subjects:	arterial hypertension valsartan smoking
Online Access:	https://www.rpcardio.online/jour/article/view/766